Evoke Pharma (EVOK) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$106714.0.
- Evoke Pharma's Other Gross PP&E Adjustments changed N/A to -$106714.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$106714.0, marking a year-over-year increase of 9419.72%. This contributed to the annual value of -$165184.0 for FY2024, which is 9101.77% up from last year.
- Latest data reveals that Evoke Pharma reported Other Gross PP&E Adjustments of -$106714.0 as of Q3 2025.
- Evoke Pharma's 5-year Other Gross PP&E Adjustments high stood at -$13370.0 for Q3 2023, and its period low was -$2.0 million during Q4 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$121432.0 (2021), whereas its average is -$451239.4.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 21286.72% in 2022, then surged by 9129.96% in 2023.
- Evoke Pharma's Other Gross PP&E Adjustments (Quarter) stood at -$1.4 million in 2021, then plummeted by 37.09% to -$2.0 million in 2022, then grew by 5.89% to -$1.8 million in 2023, then surged by 91.02% to -$165184.0 in 2024, then surged by 35.4% to -$106714.0 in 2025.
- Its Other Gross PP&E Adjustments was -$106714.0 in Q3 2025, compared to -$122938.0 in Q2 2025 and -$138758.0 in Q1 2025.